12-Week Exercise Program Targets Body Composition in Breast Cancer Survivors
A completed trial examines how structured exercise reshapes body composition and sustains physical activity habits in breast cancer patients post-diagnosis.
Summary
This completed clinical trial from the University of Hawaii investigated whether a 12-week exercise program could produce measurable body composition changes in breast cancer patients following diagnosis. Beyond physical outcomes, researchers also explored which factors predict long-term adherence to physical activity after the structured program ends. Exercise after a cancer diagnosis is increasingly recognized as a powerful tool for improving treatment outcomes, reducing recurrence risk, and enhancing quality of life. Understanding both the physiological benefits and the behavioral predictors of sustained activity is critical for designing effective oncology rehabilitation programs. Full results are not yet publicly available from this abstract alone, but the study's completion marks an important step toward evidence-based exercise prescriptions for breast cancer survivors.
Detailed Summary
Exercise is rapidly gaining recognition as a meaningful adjunct therapy in oncology, with growing evidence suggesting it can reduce treatment-related side effects, improve body composition, lower recurrence risk, and extend overall survival. Despite this, structured exercise programs are rarely integrated into standard breast cancer care, and little is known about what drives patients to maintain activity long after a supervised intervention concludes.
This completed clinical trial, sponsored by the University of Hawaii, enrolled breast cancer patients to participate in a 12-week exercise intervention. The primary aims were twofold: first, to quantify changes in body composition — including metrics such as lean mass, fat mass, and potentially bone density — attributable to the exercise program; and second, to identify the psychosocial, motivational, and clinical factors that predict sustained physical activity beyond the trial period.
Body composition is a particularly important outcome in this population. Breast cancer treatment, including chemotherapy and hormonal therapies, frequently causes fat gain and muscle loss, a shift that worsens metabolic health and may elevate recurrence risk. An effective exercise prescription could counteract these changes meaningfully.
The behavioral sustainability question is equally critical. Many supervised exercise trials demonstrate benefit during the program, but activity levels often decline sharply once formal support is withdrawn. Identifying predictors of sustained exercise adherence could help clinicians personalize follow-up strategies and support systems for survivors.
As this summary is based solely on the published abstract, specific outcome data, effect sizes, and detailed methodology are not available. The trial's completion status suggests results may be forthcoming in peer-reviewed literature. Clinicians and researchers working in integrative oncology should watch for the full publication to extract actionable prescriptive guidance for post-diagnosis exercise in breast cancer care.
Key Findings
- A 12-week structured exercise program was evaluated for body composition changes in post-diagnosis breast cancer patients.
- Researchers tracked which factors predict sustained physical activity after supervised intervention ends.
- Trial is completed, suggesting results on exercise efficacy in this population are forthcoming.
- Body composition shifts from treatment such as fat gain and muscle loss are key targets of the intervention.
- Identifying behavioral predictors of long-term adherence could improve survivorship care plans.
Methodology
This is a completed interventional clinical trial (Phase NA) sponsored by the University of Hawaii, registered on ClinicalTrials.gov (NCT04013568). Participants with breast cancer underwent a 12-week exercise program, with outcomes assessing body composition changes and predictors of post-intervention physical activity maintenance. Detailed design elements such as sample size, exercise modality, and measurement tools are not available from the abstract alone.
Study Limitations
This summary is based on the abstract only, as the full trial data are not publicly available, limiting assessment of methodology, sample size, effect sizes, and statistical rigor. The absence of a published results section means no conclusions about efficacy can be drawn at this time. The trial was conducted at a single institution, which may limit generalizability across diverse breast cancer populations.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.